Navigation Links
Marken Announces Its New Logistics Operating System: Maestro™
Date:12/13/2011

LONDON, Dec. 13, 2011 /PRNewswire/ -- Marken announced today that it has significantly upgraded its existing operating system with centralized web-based application exclusively designed for its growing supply chain organization.  The system, known as 'Maestro' has an innovative flexible architecture which will enable extensive tracking of shipments, integrated documentation, client reporting and performance monitoring.  It is designed explicitly for ease of integration with client's systems to meet their growing requirements with temperature and time sensitive drugs to be shipped worldwide. Its interfaces and flexible structure enables each of its clients to input and track relevant data connected with a clinical trial and manage the hand-offs between shipments from site to lab and country to country.  This new operating system, when coupled with Marken's new Solo™ system for its depot operations, will allow Marken to manage the complete inbound and outbound cycle for clinical trials.

(Logo:  http://photos.prnewswire.com/prnh/20110930/NY78064LOGO )

"We are very proud to announce the new Maestro system to our clients," said Cyril Leger, Chief Operating Officer, Marken.  "We have been working on this new system for many months and have incorporated our best thinking as well as feedback from our clients.  Our customer service representatives can now work more efficiently around the clock, across all of our 24 branch locations, and track shipments more precisely than ever before."

"We at Marken are committed to continuing our journey towards perfection in supply chain management," said Wes Wheeler, CEO, Marken. "We know how important it is to be trusted with our clients' proprietary drugs, kits and samples.  Time is critical in the race for new drug treatments and we want to play our part, whatever it takes."

About Marken

Marken is the leading global clinical supply chain service provider dedicated to the pharmaceutical and life sciences industries, supporting over 6,000 investigator sites in more than 100 countries. With decades of experience in the logistics, transport and distribution of temperature sensitive life saving pharmaceuticals, clinical trial supplies and specimen collection; Marken integrates depot and logistics services into solutions that extend the reach of clinical trials to even the most remote treatment naive geographies. Our team members and network of facilities bridge the distance between patients and the essential resources of life science companies.

 


'/>"/>
SOURCE Marken
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Marken Announces Appointment of Christopher OConnell as New Chief Financial Officer
2. Marken Announces the Opening of a Directly Owned Clinical Trial Supply Depot in Singapore
3. Marken Rapidly Responds to Global Supply Chain Security Measures
4. Marken Unveils New Japan Office
5. Keryx Biopharmaceuticals Announces Phase 2 Data for KRX-0401 (Perifosine) in Hodgkins Lymphoma Presented at ASH Meeting
6. Physicians Capital Investments Announces Relocation of its Corporate Headquarters to Dallas, TX
7. Stereotaxis Announces Initial Shipments of the Epoch™ Platform to Customers
8. Jazz Pharmaceuticals Announces Stockholder Vote in Favor of Transaction With Azur Pharma Limted
9. Valeant Announces the Completion of the Privatization of Afexa Life Sciences Inc.
10. Nonin Medical Announces the European Launch of EQUANOX Advance™ Neonatal/Pediatric Sensor for Regional Oximetry at PGA Conference
11. SRP Announces Plan Doc Builder for TPAs and Brokers of Healthcare Plans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/27/2017)... CAESAREA, Israel and NEW YORK , Sept. ... company with mobile health and big data solutions, today announced that its ... today. Please check your local TV listings for when The Dr. Oz ... ... ninth season this month. ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
(Date:9/19/2017)... HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that ... developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and ...
Breaking Medicine Technology:
(Date:10/13/2017)... Las Vegas, Nevada (PRWEB) , ... October 13, 2017 , ... ... of 7® Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum ... CBD dose required and providing a CBD form that can be easily incorporated into ...
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) of Somerset Hills ... specialty vendors and unique items from across the nation, this holiday-themed event will raise ... offered by the VNA. The boutique will be open Saturday, November 4 (10:00 ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in agile ... a contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise ... use of Agile methodologies in a consistent and high value manner across CMS ...
(Date:10/12/2017)... Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... centers in the U.S., announced today its plans to open a flagship location in ... will occupy the former Rooms To Go store next to Office Depot in the ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... that we intend to develop to enable prevention of a major side effect ... hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed ...
Breaking Medicine News(10 mins):